133 related articles for article (PubMed ID: 9548733)
1. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).
Lijnen HR; Ugwu F; Bini A; Collen D
Biochemistry; 1998 Apr; 37(14):4699-702. PubMed ID: 9548733
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
Ugwu F; Lemmens G; Collen D; Lijnen HR
Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
[TBL] [Abstract][Full Text] [Related]
4. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9).
Patterson BC; Sang QA
J Biol Chem; 1997 Nov; 272(46):28823-5. PubMed ID: 9360944
[TBL] [Abstract][Full Text] [Related]
5. Human glioma cell BT325 expresses a proteinase that converts human plasminogen to kringle 1-5-containing fragments.
Li F; Yang J; Liu X; He P; Ji S; Wang J; Han J; Chen N; Yao L
Biochem Biophys Res Commun; 2000 Nov; 278(3):821-5. PubMed ID: 11095991
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin-like molecules are generated by snake venom metalloproteinases.
Ho PL; Serrano SM; Chudzinski-Tavassi AM; Moura da Silva AM; Mentele R; Caldas C; Oliva ML; Batista IF; Oliveira ML
Biochem Biophys Res Commun; 2002 Jun; 294(4):879-85. PubMed ID: 12061789
[TBL] [Abstract][Full Text] [Related]
7. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
[TBL] [Abstract][Full Text] [Related]
8. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
[TBL] [Abstract][Full Text] [Related]
9. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
11. Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium Sp.
Lijnen HR; Van Hoef B; Ugwu F; Collen D; Roelants I
Biochemistry; 2000 Jan; 39(2):479-88. PubMed ID: 10631010
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and cellular fibrinolytic activity.
Lijnen HR
Biochemistry (Mosc); 2002 Jan; 67(1):92-8. PubMed ID: 11841344
[TBL] [Abstract][Full Text] [Related]
13. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
[TBL] [Abstract][Full Text] [Related]
14. TIMP-1 contact sites and perturbations of stromelysin 1 mapped by NMR and a paramagnetic surface probe.
Arumugam S; Hemme CL; Yoshida N; Suzuki K; Nagase H; Berjanskii M; Wu B; Van Doren SR
Biochemistry; 1998 Jul; 37(27):9650-7. PubMed ID: 9657677
[TBL] [Abstract][Full Text] [Related]
15. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin and plasminogen share binding to endothelial cell surface actin.
Dudani AK; Ben-Tchavtchavadze M; Porter S; Tackaberry E
Biochem Cell Biol; 2005 Feb; 83(1):28-35. PubMed ID: 15746964
[TBL] [Abstract][Full Text] [Related]
17. Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator.
Arza B; Hoylaerts MF; Félez J; Collen D; Lijnen HR
Eur J Biochem; 2000 Nov; 267(21):6378-84. PubMed ID: 11029580
[TBL] [Abstract][Full Text] [Related]
18. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
[TBL] [Abstract][Full Text] [Related]
19. Angiostatin generation by human pancreatic cancer.
O'Mahony CA; Seidel A; Albo D; Chang H; Tuszynski GP; Berger DH
J Surg Res; 1998 Jun; 77(1):55-8. PubMed ID: 9698533
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]